Amy W Schulman - Net Worth and Insider Trading

Amy W Schulman Net Worth

The estimated net worth of Amy W Schulman is at least $9 Million dollars as of 2024-12-14. Amy W Schulman is the Executive Vice President of Pfizer Inc and owns about 227,003 shares of Pfizer Inc (PFE) stock worth over $6 Million. Amy W Schulman is the Director of Alnylam Pharmaceuticals Inc and owns about 8,436 shares of Alnylam Pharmaceuticals Inc (ALNY) stock worth over $2 Million. Amy W Schulman is also the Director of Zoetis Inc and owns about 5,000 shares of Zoetis Inc (ZTS) stock worth over $890,900. Besides these, Amy W Schulman also holds Cyclerion Therapeutics Inc (CYCN) , SQZ Biotechnologies Co (SQZB) . Details can be seen in Amy W Schulman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Amy W Schulman has not made any transactions after 2024-06-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Amy W Schulman

To

Amy W Schulman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Amy W Schulman owns 13 companies in total, including Alnylam Pharmaceuticals Inc (ALNY) , Cyclerion Therapeutics Inc (CYCN) , and Hudson Executive Investment Corp (HECCU) among others .

Click here to see the complete history of Amy W Schulman’s form 4 insider trades.

Insider Ownership Summary of Amy W Schulman

Ticker Comapny Transaction Date Type of Owner
ALNY Alnylam Pharmaceuticals Inc 2024-06-25 director
CYCN Cyclerion Therapeutics Inc 2019-04-08 director
HECCU Hudson Executive Investment Corp 2020-06-08 director
LIMIT LIMIT 2017-01-01 director
LIMIT LIMIT 2017-11-15 director
LIMIT LIMIT 2018-04-24 director
LIMIT LIMIT 2015-06-09 director
LIMIT LIMIT 2013-05-15 Senior Vice President
LIMIT LIMIT 2013-02-06 director
LIMIT LIMIT 2021-12-13 director & 10 percent owner
LIMIT LIMIT 2020-06-08 director
LIMIT LIMIT 2021-01-25 director
LIMIT LIMIT 2021-01-25 director

Amy W Schulman Latest Holdings Summary

Amy W Schulman currently owns a total of 5 stocks. Among these stocks, Amy W Schulman owns 227,003 shares of Pfizer Inc (PFE) as of May 15, 2013, with a value of $6 Million and a weighting of 65.35%. Amy W Schulman owns 8,436 shares of Alnylam Pharmaceuticals Inc (ALNY) as of June 25, 2024, with a value of $2 Million and a weighting of 23.3%. Amy W Schulman also owns 5,000 shares of Zoetis Inc (ZTS) as of February 6, 2013, with a value of $890,900 and a weighting of 10.03%. The other 2 stocks Cyclerion Therapeutics Inc (CYCN) , SQZ Biotechnologies Co (SQZB) have a combined weighting of 1.32% among all his current holdings.

Latest Holdings of Amy W Schulman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PFE Pfizer Inc 2013-05-15 227,003 25.58 5,806,737
ALNY Alnylam Pharmaceuticals Inc 2024-06-25 8,436 245.44 2,070,532
ZTS Zoetis Inc 2013-02-06 5,000 178.18 890,900
CYCN Cyclerion Therapeutics Inc 2019-04-08 31,681 3.43 108,666
SQZB SQZ Biotechnologies Co 2021-12-13 301,955 0.03 8,304

Holding Weightings of Amy W Schulman


Amy W Schulman Form 4 Trading Tracker

According to the SEC Form 4 filings, Amy W Schulman has made a total of 0 transactions in Pfizer Inc (PFE) over the past 5 years. The most-recent trade in Pfizer Inc is the sale of 70,000 shares on May 15, 2013, which brought Amy W Schulman around $2 Million.

According to the SEC Form 4 filings, Amy W Schulman has made a total of 2 transactions in Alnylam Pharmaceuticals Inc (ALNY) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Alnylam Pharmaceuticals Inc is the sale of 8,500 shares on June 25, 2024, which brought Amy W Schulman around $2 Million.

According to the SEC Form 4 filings, Amy W Schulman has made a total of 0 transactions in Zoetis Inc (ZTS) over the past 5 years. The most-recent trade in Zoetis Inc is the acquisition of 5,000 shares on February 6, 2013, which cost Amy W Schulman around $130,000.

More details on Amy W Schulman's insider transactions can be found in the Insider Trading History of Amy W Schulman table.

Insider Trading History of Amy W Schulman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Amy W Schulman Trading Performance

GuruFocus tracks the stock performance after each of Amy W Schulman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Amy W Schulman is -6.89%. GuruFocus also compares Amy W Schulman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Amy W Schulman within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Amy W Schulman's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Amy W Schulman

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 11.58 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 9.08 LIMIT LIMIT LIMIT LIMIT LIMIT

Amy W Schulman Ownership Network

Ownership Network List of Amy W Schulman

No Data

Ownership Network Relation of Amy W Schulman

Insider Network Chart

Amy W Schulman Owned Company Details

What does Alnylam Pharmaceuticals Inc do?

Who are the key executives at Alnylam Pharmaceuticals Inc?

Amy W Schulman is the director of Alnylam Pharmaceuticals Inc. Other key executives at Alnylam Pharmaceuticals Inc include CMO & EVP Dev & Med Affairs Pushkal Garg , EVP & Chief Commercial Officer Tolga Tanguler , and Chief Financial Officer Jeffrey V. Poulton .

Alnylam Pharmaceuticals Inc (ALNY) Insider Trades Summary

Over the past 18 months, Amy W Schulman made 2 insider transaction in Alnylam Pharmaceuticals Inc (ALNY) with a net sale of 30,200. Other recent insider transactions involving Alnylam Pharmaceuticals Inc (ALNY) include a net sale of 57,750 shares made by Yvonne Greenstreet , a net sale of 13,738 shares made by Pushkal Garg , and a net sale of 7,321 shares made by Jeffrey V. Poulton .

In summary, during the past 3 months, insiders sold 14,804 shares of Alnylam Pharmaceuticals Inc (ALNY) in total and bought 0 shares, with a net sale of 14,804 shares. During the past 18 months, 263,932 shares of Alnylam Pharmaceuticals Inc (ALNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 263,932 shares.

Alnylam Pharmaceuticals Inc (ALNY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Alnylam Pharmaceuticals Inc Insider Transactions

No Available Data

Amy W Schulman Mailing Address

Above is the net worth, insider trading, and ownership report for Amy W Schulman. You might contact Amy W Schulman via mailing address: Pfizer Inc. Attn: Corporate Secretary, 235 East 42nd Street, New York Ny 10017.